Clinical Trial

A Study of the ReCor Medical Paradise System in Clinical Hypertension

Study acronym: RADIANCE-HTN
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
RADIANCE-HTN is a randomized, double-blind, sham controlled, 2-cohort study (TRIO and SOLO) designed to demonstrate efficacy and document the safety of the Paradise Renal Denervation System in two distinct populations of hypertensive subjects.
Protocol Amendment History 57 amendments
This ClinicalTrials.gov record has been amended 57 times since 2016-01-05; most recent amendment 2026-03-31.
Status change: Recruiting → Active, Not Recruiting 2020-04-06
Status change: Not Yet Recruiting → Recruiting 2016-03-11
Trial Details
NCT Number NCT02649426
Lead Sponsor ReCor Medical, Inc.
Conditions Hypertension, Vascular Diseases
Enrollment 282 participants
Start Date 2016-03
Primary Completion 2020-09 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-21